osimertinib
astrazeneca
['sclc', 'lcsm,(-blcsm)', 'nsclc', 'osimertinib']
#asco23 #lcsm first up: phase ii trial of neoadjuvant #osimertinib for surgically resectable #egfr-mutated #nsclc - dr. aredo 
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | Incoming Chair @ASCO #CCC | Tweets my own | COI: https://t.co/ghKU8KhBvl